Share This Page
Drug Price Trends for MOTION SICKNESS RLF
✉ Email this page to a colleague
Average Pharmacy Cost for MOTION SICKNESS RLF
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MOTION SICKNESS RLF 25 MG TAB | 46122-0535-51 | 0.12117 | EACH | 2025-03-19 |
| MOTION SICKNESS RLF 25 MG TAB | 70000-0097-01 | 0.12117 | EACH | 2025-03-19 |
| MOTION SICKNESS RLF 25 MG TAB | 46122-0535-51 | 0.12539 | EACH | 2025-02-19 |
| MOTION SICKNESS RLF 25 MG TAB | 70000-0097-01 | 0.12539 | EACH | 2025-02-19 |
| MOTION SICKNESS RLF 25 MG TAB | 70000-0097-01 | 0.12073 | EACH | 2025-01-22 |
| MOTION SICKNESS RLF 25 MG TAB | 46122-0535-51 | 0.12073 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Motion Sickness Treatment Market Analysis and Price Projections
Market Overview
The motion sickness treatment market is poised for significant growth, driven by several key factors. Here are the main points to consider:
Market Size and Growth Rate
The global motion sickness treatment market was valued at $393.7 million in 2021 and is projected to reach $525 million by 2031, growing at a Compound Annual Growth Rate (CAGR) of 2.9% from 2022 to 2031[3][4].
Regional Dominance
North America is expected to maintain its dominance in the market, holding a significant market share of approximately 40.2% by 2031. This is largely due to the region's well-developed healthcare infrastructure, government support for quality healthcare, and the presence of key market players offering high-quality motion sickness medications[2][4].
Drivers of Market Growth
- Increasing Tourism: The rise in tourism, especially in regions like North America and Europe, is a key driver. For instance, America recorded strong growth in tourist arrivals in 2022, reaching 65% of pre-pandemic levels[1][4].
- Adoption of Prescription Drugs: The increasing adoption of highly expensive prescription drugs, particularly anticholinergics like scopolamine and its transdermal patches, is boosting market growth[2][4].
- Awareness and Healthcare Infrastructure: Increased awareness about motion sickness and its treatment options, along with improved healthcare infrastructure in emerging markets, are significant contributors to market growth[2][3].
Market Segmentation
By Drug Class
- Anticholinergics: This segment is expected to grow at the fastest rate during the forecast period due to their long-lasting relief, better efficacy, and fewer side effects. Scopolamine patches are the most commonly used anticholinergics for motion sickness[2][4].
- Antihistamines: These are widely used and available in oral forms such as tablets, capsules, and pills. The oral segment dominated the market in terms of revenue in 2021[2].
By Route of Administration
- Oral: This segment dominated the market in 2021 due to the high demand for antihistaminic medications available in oral forms[2].
- Transdermal: The use of transdermal patches, such as scopolamine patches, is increasing due to their convenience and effectiveness[2][4].
Competitive Landscape
Key players in the motion sickness treatment market include WellSpring Pharmaceutical Corporation, Zydus Lifesciences Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Abbott Laboratories, and Baxter International Inc. These companies are focusing on manufacturing activities to launch generic versions of existing branded medications, which is expected to further boost the market[3].
Impact of COVID-19
The COVID-19 pandemic had a significant impact on the market, particularly due to the reduction in international tourist arrivals. However, as restrictions are lifted and tourism resumes, the market is expected to expand, with international arrivals anticipated to return to pre-pandemic levels in the next few years[4].
Price Projections and Market Value
Current Market Value
The global motion sickness treatment market was valued at $393.7 million in 2021[3].
Projected Market Value
The market is estimated to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031[3].
Regional Market Value
- North America: Expected to hold a significant market share of 40.2% by 2031, driven by the increasing adoption of expensive prescription drugs and well-developed healthcare infrastructure[2].
- Asia-Pacific: Expected to grow at the highest rate during the forecast period, driven by the presence of pharmaceutical companies, growth in purchasing power, and increased healthcare expenditure[3].
Key Takeaways
- The motion sickness treatment market is driven by increasing tourism, adoption of prescription drugs, and improved healthcare infrastructure.
- North America is expected to dominate the market, while Asia-Pacific is anticipated to grow at the highest rate.
- Anticholinergics, particularly scopolamine patches, are expected to be a significant segment due to their efficacy and convenience.
- The market is projected to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031.
FAQs
What is the current market size of the motion sickness treatment market?
The global motion sickness treatment market was valued at $393.7 million in 2021[3].
What is the projected market size of the motion sickness treatment market by 2031?
The market is estimated to reach $525 million by 2031[3].
Which region is expected to dominate the motion sickness treatment market?
North America is expected to hold a significant market share of 40.2% by 2031[2].
What are the key drivers of the motion sickness treatment market?
Key drivers include increasing tourism, adoption of prescription drugs, and improved healthcare infrastructure[2][3].
Which segment is expected to grow the fastest in the motion sickness treatment market?
The anticholinergics segment, particularly scopolamine patches, is expected to grow at the fastest rate during the forecast period[2][4].
How has the COVID-19 pandemic affected the motion sickness treatment market?
The pandemic reduced international tourist arrivals, impacting market growth. However, as restrictions are lifted, the market is expected to expand[4].
Sources
- Mordor Intelligence: Motion Sickness Treatment Market Trends[1]
- Allied Market Research: Motion Sickness Treatment Market Forecast[2]
- Allied Market Research: Motion Sickness Treatment Market Statistics | Projection - 2031[3]
- Mordor Intelligence: Motion Sickness Treatment Market - Trends & Size[4]
- Transparency Market Research: Motion Sickness Treatment Market Analysis Report 2026[5]
More… ↓
